Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays.
There are several bacterial polysaccharides (PSs) which contain a terminal lipid moiety. It has been postulated that these terminal lipid moieties anchor the PSs to the outer membrane of the bacteria. Our studies have shown that incubation of native PS from group C Neisseria meningitidis or Haemophilus influenzae type b with isolated outer membrane vesicles results in association of a portion of the PS with the vesicles. Removal of the terminal lipid from the PS by treatment with phospholipase A2 or phospholipase D eliminates this association. In other studies, it was shown that delipidated PSs are not suitable as solid-phase antigens in a currently used enzyme-linked immunosorbent assay (ELISA). Measurement of antibody units in the reference sera by using delipidated PSs as antigens in an ELISA yielded negligible absorbance compared with native PSs when methylated human serum albumin was used to coat the PSs to the plate. Nevertheless, phospholipase A2 and phospholipase D treatment did not noticeably affect antigenic epitopes, since soluble group C PS without the terminal lipid bound antibody as effectively as the native PS did, as measured by a competitive inhibition assay. Both hydrophobic and electrostatic interactions are important for the binding of group C N. meningitidis PS to the ELISA plate, while charge interactions seem to be sufficient for binding the more negatively charged H. influenzae type b PS.
Arakere
G
G
Center for Biologics Evaluation and Research, Division of Bacterial Products, Bethesda, Maryland 20892.
Lee
A L
AL
Frasch
C E
CE
D000942:Antigens, Bacterial / Q000737:chemistry*; D002462:Cell Membrane / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005227:Fatty Acids / Q000737:chemistry; D006193:Haemophilus influenzae / Q000737:chemistry* / Q000276:immunology / Q000648:ultrastructure; D009682:Magnetic Resonance Spectroscopy; D008970:Molecular Weight; D009345:Neisseria meningitidis / Q000737:chemistry* / Q000276:immunology / Q000648:ultrastructure; D010739:Phospholipase D / Q000494:pharmacology; D010741:Phospholipases A / Q000494:pharmacology; D054467:Phospholipases A2; D011135:Polysaccharides, Bacterial / Q000737:chemistry*
D000942:Antigens, Bacterial; D005227:Fatty Acids; D011135:Polysaccharides, Bacterial; D010741:Phospholipases A; D054467:Phospholipases A2; D010739:Phospholipase D